The global predictive genetic testing and consumer/wellness genomics market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing awareness about the benefits of predictive genetic testing, rising incidence of chronic diseases, and growing demand for personalized healthcare services. Predictive genetic testing is used to identify an individual's risk for developing a disease or condition in the future. It can be used to predict an individual's risk for developing breast cancer or ovarian cancer in women, cardiovascular diseases in men and women, diabetes mellitus type 2 (DM2), colon cancer, Alzheimer's disease (AD), Parkinson's disease (PD), hereditary hemochromatosis (HH) and other conditions. Consumer genomics refers to the use of genomic data by consumers themselves for their own health management purposes without any medical intervention from a healthcare professional. Wellness genomics refers to genomic data that are collected by wellness companies with no intention of providing medical interventions but rather provide information on lifestyle choices that may affect one’s health status over time. The global predictive genetic testing and consumer/wellness genomics market has been segmented on the basis of type into predictive testing and consumer/wellness genomics; application into breast & ovarian cancer screening & monitoring cardiometabolic disorders screening & monitoring diabetic screening & monitoring colon cancer; region into North America Latin America Europe Asia Pacific Middle East Africa; end user into hospitals clinics laboratories research institutes pharmaceutical companies wellness companies insurance providers government agencies others; end user industry into life sciences industry pharmaceuticals industry biotechnology industry food processing industry agriculture sector others; end-user country into US, Canada Mexico Brazil Argentina Chile Colombia Peru Ecuador Venezuela Paraguay Uruguay Costa Rica Panama Guatemala El Salvador Honduras Nicaragua Jamaica Dominican Republic Haiti Jamaica Trinidad And Tobago Belize Honduras Antigua And Barbuda Saint Kitts And Nevis Dominica Grenada Saint Lucia Saint Vincent And The Grenadines Suriname Guyana Haiti Turks And Caicos Islands Bahamas Bermuda Aruba Cayman Islands Puerto Rico Virgin Islands British Virgin Islands United States Minor Outlying Islands American Samoa Guam Northern Mariana Islands Marshall Island Palau Micronesia Federated States Of Micronesia Nauru Niue Cook Island New Zealand Australia Japan China India South Korea Taiwan Thailand Indonesia Malaysia Philippines Pakistan Bangladesh Sri Lanka Nepal Bhutan Afghanistan Iran Iraq Qatar Kuwait Saudi Arabia Oman Jordan Lebanon Syria Yemen Egypt Libya Sudan Tunisia Algeria Morocco Tunisia Algeria Morocco Nigeria Chad Togo Cameroon Benin Burkina Faso Burundi Central African Republic Congo Djibouti Eritrea Ethiopia Gabon Gambia Ghana Guinea Guinea-Bissau Ivory Coast Kenya Lesotho Liberia Madagascar Malawi Mali Mauritania Mauritius Mozambique Namibia Niger Nigeria Rwanda Senegal Sierra Leone Somalia South Africa Sudan Swaziland Tanzania Uganda Zambia Zimbabwe.
- Predictive Genetic Testing And Consumer/Wellness Genomics market growth is driven by the need for personalized healthcare.
Industry Growth Insights published a new data on “Predictive Genetic Testing And Consumer/Wellness Genomics Market”. The research report is titled “Predictive Genetic Testing And Consumer/Wellness Genomics Market research by Types (Predictive Testing, Consumer Genomics, Wellness Genomics), By Applications (Breast & Ovarian Cancer, Cardiovascular screening, Diabetic Screening & Monitoring, Colon Cancer, Other), By Players/Companies Illumina, BGI, Genesis Genetics, Myriad Genetics, 23andMe, Inc, Color Genomics Inc, Pathway Genomics, ARUP Laboratories”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Predictive Genetic Testing And Consumer/Wellness Genomics Market Research Report
By Type
Predictive Testing, Consumer Genomics, Wellness Genomics
By Application
Breast & Ovarian Cancer, Cardiovascular screening, Diabetic Screening & Monitoring, Colon Cancer, Other
By Companies
Illumina, BGI, Genesis Genetics, Myriad Genetics, 23andMe, Inc, Color Genomics Inc, Pathway Genomics, ARUP Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Report Segments:
The global Predictive Genetic Testing And Consumer/Wellness Genomics market is segmented on the basis of:
Types
Predictive Testing, Consumer Genomics, Wellness Genomics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast & Ovarian Cancer, Cardiovascular screening, Diabetic Screening & Monitoring, Colon Cancer, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- BGI
- Genesis Genetics
- Myriad Genetics
- 23andMe, Inc
- Color Genomics Inc
- Pathway Genomics
- ARUP Laboratories
Highlights of The Predictive Genetic Testing And Consumer/Wellness Genomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Predictive Testing
- Consumer Genomics
- Wellness Genomics
- By Application:
- Breast & Ovarian Cancer
- Cardiovascular screening
- Diabetic Screening & Monitoring
- Colon Cancer
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Predictive Genetic Testing And Consumer/Wellness Genomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Predictive genetic testing is a type of genomic medicine that uses data from an individual's genome to predict their risk for certain diseases or conditions. Consumer/wellness genomics is a term used to describe the use of genomic information and analytics to improve health and well-being.
Some of the major companies in the predictive genetic testing and consumer/wellness genomics market are Illumina, BGI, Genesis Genetics, Myriad Genetics, 23andMe, Inc, Color Genomics Inc, Pathway Genomics, ARUP Laboratories.
The predictive genetic testing and consumer/wellness genomics market is expected to register a CAGR of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Predictive Genetic Testing And Consumer/Wellness Genomics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Predictive Genetic Testing And Consumer/Wellness Genomics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Predictive Genetic Testing And Consumer/Wellness Genomics Market - Supply Chain
4.5. Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Forecast
4.5.1. Predictive Genetic Testing And Consumer/Wellness Genomics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Predictive Genetic Testing And Consumer/Wellness Genomics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Predictive Genetic Testing And Consumer/Wellness Genomics Market Absolute $ Opportunity
5. Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Type
5.3.1. Predictive Testing
5.3.2. Consumer Genomics
5.3.3. Wellness Genomics
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Application
6.3.1. Breast & Ovarian Cancer
6.3.2. Cardiovascular screening
6.3.3. Diabetic Screening & Monitoring
6.3.4. Colon Cancer
6.3.5. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Predictive Genetic Testing And Consumer/Wellness Genomics Demand Share Forecast, 2019-2029
9. North America Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Application
9.4.1. Breast & Ovarian Cancer
9.4.2. Cardiovascular screening
9.4.3. Diabetic Screening & Monitoring
9.4.4. Colon Cancer
9.4.5. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Type
9.7.1. Predictive Testing
9.7.2. Consumer Genomics
9.7.3. Wellness Genomics
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Predictive Genetic Testing And Consumer/Wellness Genomics Demand Share Forecast, 2019-2029
10. Latin America Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Application
10.4.1. Breast & Ovarian Cancer
10.4.2. Cardiovascular screening
10.4.3. Diabetic Screening & Monitoring
10.4.4. Colon Cancer
10.4.5. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Type
10.7.1. Predictive Testing
10.7.2. Consumer Genomics
10.7.3. Wellness Genomics
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Predictive Genetic Testing And Consumer/Wellness Genomics Demand Share Forecast, 2019-2029
11. Europe Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Application
11.4.1. Breast & Ovarian Cancer
11.4.2. Cardiovascular screening
11.4.3. Diabetic Screening & Monitoring
11.4.4. Colon Cancer
11.4.5. Other 11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Type
11.7.1. Predictive Testing
11.7.2. Consumer Genomics
11.7.3. Wellness Genomics
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Predictive Genetic Testing And Consumer/Wellness Genomics Demand Share, 2019-2029
12. Asia Pacific Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Application
12.4.1. Breast & Ovarian Cancer
12.4.2. Cardiovascular screening
12.4.3. Diabetic Screening & Monitoring
12.4.4. Colon Cancer
12.4.5. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Type
12.7.1. Predictive Testing
12.7.2. Consumer Genomics
12.7.3. Wellness Genomics
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Predictive Genetic Testing And Consumer/Wellness Genomics Demand Share, 2019-2029
13. Middle East & Africa Predictive Genetic Testing And Consumer/Wellness Genomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Application
13.4.1. Breast & Ovarian Cancer
13.4.2. Cardiovascular screening
13.4.3. Diabetic Screening & Monitoring
13.4.4. Colon Cancer
13.4.5. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Predictive Genetic Testing And Consumer/Wellness Genomics Market Size and Volume Forecast by Type
13.7.1. Predictive Testing
13.7.2. Consumer Genomics
13.7.3. Wellness Genomics
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Predictive Genetic Testing And Consumer/Wellness Genomics Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Predictive Genetic Testing And Consumer/Wellness Genomics Market: Market Share Analysis
14.2. Predictive Genetic Testing And Consumer/Wellness Genomics Distributors and Customers
14.3. Predictive Genetic Testing And Consumer/Wellness Genomics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Illumina
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BGI
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Genesis Genetics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Myriad Genetics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. 23andMe, Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Color Genomics Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pathway Genomics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ARUP Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook